High Quality 3,5-hydroxypentyl Olivetol in Stock Powder Purity 99% CAS 500-66-3
Product name |
Olivetol |
CAS number |
500-66-3 |
Molecular formula |
C11H16O2 |
Molecular weight |
180.24 |
Appearance |
White powder |
Purity |
99.0% |
Function |
1. The aromatherapy properties of cedarwood oil are antiseborrhoeic, antiseptic, antispasmodic, astringent, diuretic, emmenagogue, expectorant, fungicide insecticide, sedative and tonic.
2. It has a calming and soothing effect on the mind and is of great help in conditions associated with anxiety and nervous tension.
3. Cedarwood oil benefits the skin by its sedating ability which relieves itching.
4. Its astringent action is great for acne, oily skin as well as for hair and dandruff.
5. It helps with chest and urinary infections acts as a general tonic and has a pronounced effect on mucus membranes. It is also useful in cases of arthritis and rheumatism. 6. This high grade fragrance oil is excellent to scent candles, freshen potpourri, in soap making, massage oils and bath oil. It is also used as a perfume body oil also.It adds a warm quality to fragrances.
6. It is also good for dry hair because it increases the ability of the skin and scalp to hold in water.
7. Cedarwood is excellent repellent used for mothproofing and other insects. |
Discribe |
Olivetol, also known as 5-pentylresorci nol or 5-pentyl-1,3-benzenediol, is an organic compound found in certain species of lichen; it is also a precursor in various syntheses .
Olivetol is a member of the class of resorci nols that is resorci nol in which the hydrogen at position 5 is replaced by a pentyl group. It has a role as a lichen metabolite. |
It is believed that Olivetol acts as a competitive inhibitor of the cannab inoid receptors CB1 and CB2. Due to its smaller size and its lack of more functional groups, it is believed that Olivetol binds more tightly and/or more aggressively to the cannab inoid receptors CB1 and/or CB2 and has a much lower dissociation constant, allowing it to stay in the active site of the CB receptors for a longer period of time while not activating the receptor, thereby not causing the change in GABA release that is believed to be the mechanism of THC's psychotropic effects.
The effects of Olivetol on a person who has ingested THC will include but are not limited to clarity of mind, improved vision, increased ability to focus, improved motor skills, and reduction in any other symptoms of THC consumption. A number of real-life, non-clinical trials have been performed by volunteers, to test the effects of the consumption of embodiments of the present invention, the conditions and results of which are described as follows. All tests were performed in "real life," rather than clinical conditions. Various methods of consumption of canna bis were used, such as consumption of edibles, inhalation of canna bis smoke, or inhalation of vapor, depending upon the volunteer's preference. Some subjects reported their pre-consumption mood, pain level, etc., as well as their level of experience with consumption of canna bis.
After sufficient exposure to canna bis, each subject indicated when their euphoria or "high" had reached a high level or a peak. Then, the subject took one or more oral doses of an embodiment of the present invention, containing 30 mg of Olivetol combined with edible oil in a "softgel" pill. A timer was started and the subject then reported when they felt an awareness of a decrease or reduction in their euphoria or other canna bis effects, as well as their subjective feelings, mood, pain level or other observations, until they self-reported that their canna bis effects were concluded, hi the majority of cases, subjects noticed a reduction in the effects of canna bis consumption between four to ten minutes, and most commonly six to seven minutes, after talcing a dose of an embodiment of the present invention. Most subjects reported some improved level of mental clarity. However, most subjects also reported that the beneficial effects of their canna bis consumption, such as improved mood or pain reduction, remained even after the euphoric feeling and other physical effects associated with canna bis use declined following their use of a dose or two of an embodiment of the present invention.